Crown Resorts has appealed a ruling in a shareholder class action against it allowing 18 former employees, who were jailed as part of the Chinese government’s crackdown on gambling, to answer questions about its business in China.
The High Court will not review an appeals court’s decision to approve a $64 million settlement in litigation over the failure of Banksia Securities while rejecting the funder’s commission and legal fees.
TV giant Foxtel wants another shot at opposing a trade mark by telco China Unicom, after a judge let stand an IP Australia decision refusing to revoke the trade mark when law firm Allens missed a deadline for opposing the mark.
The Geelong Football Club has launched Federal Court proceedings against a promotional firm it claims passed itself off as the famous AFL club in order to procure payments from members.
The ACCC will not oppose Origin Energy’s sale of the Ironback coal seam gas project to joint venture partner Australia Pacific for $231 million, less than a third of what it paid for the project ten years ago.
The Commonwealth Director of Public Prosecutions has pared its criminal cartel case against Country Care Group and two individuals, cutting over 100 charges in an indictment that details two alleged cartel agreements the Australian mobility equipment provider entered into in relation to bids on NSW government tenders.
The High Court has granted ASIC special leave to appeal a judgment that let a former director of Gold Coast finance company MFS Group partially off the hook for $147.5 million in misappropriated funds, after ASIC argued the High Court should intervene to clarify the scope of the word “officer” under the Corporations Act.
US hedge fund Oaktree Capital has placed fund manager Blue Sky Alternative Investments into receivership, following a tumultuous period marked by the loss of senior executives and three shareholder class action investigations amid concerns about the company’s method for valuing its assets under management.
Nine Entertainment Company has resolved a defamation lawsuit brought by a prominent Sydney cosmetic surgeon over an article that appeared in the Sydney Morning Herald about the death of a criminal figure during a nose job procedure.
GlaxoSmithKline has defeated claims by the ACCC that revised packaging for its now-discontinued pain killer Osteo Gel misled consumers. The drug maker will face penalties for earlier violations it admitted to, but the court hinted the damages will be nowhere near the $6 million competitor Reckitt Benckiser faced in a similar case.